Patients with chronic granulomatous disease (CGD), who are deficient in NADPH oxidase activity, and individuals who are completely deficient in myeloperoxidase (ΔMPO; Figure S1A) are susceptible to opportunistic infections, particularly to fungal pathogens (Nauseef, 2007). The gene discussed is FMO5; the disease is chronic granulomatous disease.